masshiro glutathione Japan brand introduces in different forms for Asian consumers masshiro glutathione Glow from within

View Study [5]"Efficacy and safety of CagriSema in type 2 diabetes" Frias JP et al., 2023 Finding: In people with type 2 diabetes, CagriSema achieved 15.6% weight loss versus 5.1% with semaglutide alone over 32 weeks, with comparable HbA1c reductions and good tolerability

IGF-1 and Hormone Optimization One of the most significant advantages of IGF-1 therapy is its synergistic relationship with other hormones

Cagrilintide is evaluated in laboratory research to study amylin receptor and appetite-regulation pathway research

GHK is also available in other forms

Why Choose Direct Peptides

DSIP targets deep sleep deficiency and acute insomnia